Anti-malarial Portfolio
Malaria
ApprovedCommercial
Key Facts
About Strides Pharma
Strides Pharma is a global pharmaceutical company headquartered in Bengaluru, India, with a core mission to provide affordable, high-quality generic medicines worldwide. The company has established itself as a leader in niche and complex therapeutic segments, including anti-retrovirals, anti-malarials, and softgel technologies, with a significant footprint in the US, Africa, Asia, and other regulated markets. Its strategic direction involves expanding its portfolio of complex generics, biosimilars, and specialty products while leveraging its robust manufacturing and R&D capabilities. Key achievements include a successful IPO, strategic acquisitions, and a consistent track record of ANDA filings and approvals in the US market.
View full company profileTherapeutic Areas
Other Malaria Drugs
| Drug | Company | Phase |
|---|---|---|
| Chloroquine Phosphate | Ipca Laboratories | Commercial |
| Malaria Vaccine (R21/Matrix-M) | Novavax | Phase 3 |
| STANDARD Q Malaria Pf/Pan Ag Test | SD BioSensor | Approved |
| Anti-malarial Portfolio (ACTs) | Bliss GVS Pharma | Approved |